An A2A adenosine receptor antagonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

ZM 241385

Item No. 20447

Technical Information
Formal Name
4-[2-[[7-amino-2-(2-furanyl)[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl]amino]ethyl]-phenol
CAS Number
139180-30-6
Molecular Formula
C16H15N7O2
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMSO: 100mMEthanol: 5 mM
λmax
228, 256 nm
SMILES
OC1=CC=C(CCNC2=NC3=NC(C4=CC=CO4)=NN3C(N)=N2)C=C1
InChi Code
InChI=1S/C16H15N7O2/c17-14-20-15(18-8-7-10-3-5-11(24)6-4-10)21-16-19-13(22-23(14)16)12-2-1-9-25-12/h1-6,9,24H,7-8H2,(H3,17,18,19,20,21,22)
InChi Key
PWTBZOIUWZOPFT-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    ZM 241385 is a potent antagonist of A2A adenosine receptors (pIC50 = 9.52 for displacement of 5’-N-ethylcarboxamidoadenosine from rat phaeochromocytoma cell membranes).1,2 It displays little or no activity at other A adenosine receptors. ZM 241385 is active in vivo.3,4 It acts as an inverse agonist at constitutively active mutants of the human A2B adenosine receptor.5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Poucher, S.M., Keddie, J.R., Singh, P., et alThe in vitro pharmacology of ZM 241385, a potent, non-xanthine A2a selective adenosine receptor antagonist. Br. J. Pharmacol. 115(6), 1096-1102 (1995).

    2. Linden, J., Thai, T., Figler, H., et alCharacterization of human A2B adenosine receptors: Radioligand binding, western blotting, and coupling to Gq in human embryonic kidney 293 cells and HMC-1 mast cells. Mol. Pharmacol. 56(4), 705-713 (1999).

    3. Keddie, J.R., Poucher, S.M., Shaw, G.R., et alIn vivo characterisation of ZM 241385, a selective adenosine A2A receptor antagonist. Eur. J. Pharmacol. 301(1-3), 107-113 (1996).

    4. Poucher, S.M., Keddie, J.R., Brooks, R., et alPharmacodynamics of ZM 241385, a potent A2a adenosine receptor antagonist, after enteric administration in rat, cat and dog. J. Pharm. Pharmacol. 48(6), 601-606 (1996).

    5. Li, Q., Ye, K., Blad, C.C., et alZM241385, DPCPX, MRS1706 are inverse agonists with different relative intrinsic efficacies on constitutively active mutants of the human adenosine A2B receptor. J. Pharmacol. Exp. Ther. 320(2), 637-645 (2007).